113 related articles for article (PubMed ID: 36426068)
1. Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases.
Schulz TU; Zierold S; Sachse MM; Pesch G; Tomsitz D; Schilbach K; Kähler KC; French LE; Heinzerling L
Data Brief; 2022 Dec; 45():108676. PubMed ID: 36426068
[TBL] [Abstract][Full Text] [Related]
2. Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.
Schulz TU; Zierold S; Sachse MM; Pesch G; Tomsitz D; Schilbach K; Kähler KC; French LE; Heinzerling L
Eur J Cancer; 2022 Nov; 176():88-99. PubMed ID: 36198246
[TBL] [Abstract][Full Text] [Related]
3. Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial.
Tolstrup LK; Pappot H; Bastholt L; Möller S; Dieperink KB
J Patient Rep Outcomes; 2022 Jan; 6(1):8. PubMed ID: 35061112
[TBL] [Abstract][Full Text] [Related]
4. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
5. Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study.
Brusniak K; Feisst M; Sebesteny L; Hartkopf A; Graf J; Engler T; Schneeweiss A; Wallwiener M; Deutsch TM
JMIR Cancer; 2021 Oct; 7(4):e25776. PubMed ID: 34636732
[TBL] [Abstract][Full Text] [Related]
6. Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer.
Allouchery M; Lombard T; Martin M; Rouby F; Sassier M; Bertin C; Atzenhoffer M; Miremont-Salame G; Perault-Pochat MC; Puyade M;
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428586
[TBL] [Abstract][Full Text] [Related]
7. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study.
DE Graaf JA; Visser-Meily JM; Schepers VP; Baars A; Kappelle LJ; Passier PE; Wermer MJ; DE Wit DC; Post MW
Eur J Phys Rehabil Med; 2021 Jun; 57(3):337-346. PubMed ID: 33448750
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitor-associated adrenal insufficiency in Chinese cancer patients: a retrospective analysis.
Cai Q; Wu W; Li X; Xu Q; Zhao L; Lv Q
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14113-14123. PubMed ID: 37553420
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of health-related quality of life and related factors in patients with brain tumors treated with rehabilitation therapy.
Watanabe T; Noto S; Natsumeda M; Kimura S; Tabata S; Ikarashi F; Takano M; Tsukamoto Y; Oishi M
J Patient Rep Outcomes; 2022 Sep; 6(1):94. PubMed ID: 36068453
[TBL] [Abstract][Full Text] [Related]
11. Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity.
Singh N; Hocking AM; Buckner JH
Immunol Rev; 2023 Sep; 318(1):81-88. PubMed ID: 37493210
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study.
Cui K; Wang Z; Zhang Q; Zhang X
Ann Transl Med; 2022 Mar; 10(5):251. PubMed ID: 35402601
[TBL] [Abstract][Full Text] [Related]
13. Evaluating health-related quality of life in gastric cancer patients in Suzhou, China.
Zhang FF; Ye L; Yin N; Xiong F; Zhao CH; Zhu YB
Ann Palliat Med; 2021 Jul; 10(7):8024-8033. PubMed ID: 34353087
[TBL] [Abstract][Full Text] [Related]
14. Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors.
Lopez-Olivo MA; Kachira JJ; Buni M; Kim ST; Lu H; Tayar JH; Duhon GF; Ruiz JI; Bingham CO; Calabrese C; Volk RJ; Suarez-Almazor ME
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568819
[TBL] [Abstract][Full Text] [Related]
15. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.
Tison A; Quéré G; Misery L; Funck-Brentano E; Danlos FX; Routier E; Robert C; Loriot Y; Lambotte O; Bonniaud B; Scalbert C; Maanaoui S; Lesimple T; Martinez S; Marcq M; Chouaid C; Dubos C; Brunet-Possenti F; Stavris C; Chiche L; Beneton N; Mansard S; Guisier F; Doubre H; Skowron F; Aubin F; Zehou O; Roge C; Lambert M; Pham-Ledard A; Beylot-Barry M; Veillon R; Kramkimel N; Giacchero D; De Quatrebarbes J; Michel C; Auliac JB; Gonzales G; Decroisette C; Le Garff G; Carpiuc I; Vallerand H; Nowak E; Cornec D; Kostine M;
Arthritis Rheumatol; 2019 Dec; 71(12):2100-2111. PubMed ID: 31379105
[TBL] [Abstract][Full Text] [Related]
17. Impact of socio-demographic and clinical characteristics on functional disability and health-related quality of life in patients with rheumatoid arthritis: a cross-sectional study from Palestine.
Al-Jabi SW; Seleit DI; Badran A; Koni A; Zyoud SH
Health Qual Life Outcomes; 2021 Oct; 19(1):241. PubMed ID: 34645455
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy to treat malignancy in patients with pre-existing autoimmunity.
Boland P; Pavlick AC; Weber J; Sandigursky S
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303614
[TBL] [Abstract][Full Text] [Related]
19. Measurement of Health-Related Quality of Life Among Colorectal Cancer Patients Using the Vietnamese Value Set of the EQ-5D-5L.
Tran BT; Pham NH; Nguyen TX; Choi KS; Sohn DK; Kim SY; Suh JK; Nguyen TD; Phan VS; Tran DT; Nguyen TT; Nguyen TTB; Nguyen MT; Oh JK
Patient Prefer Adherence; 2020; 14():2427-2437. PubMed ID: 33304097
[TBL] [Abstract][Full Text] [Related]
20. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
O'Reilly A; Hughes P; Mann J; Lai Z; Teh JJ; Mclean E; Edmonds K; Lingard K; Chauhan D; Lynch J; Au L; Ludlow A; Pattison N; Wiseman T; Turajlic S; Gore M; Larkin J; Husson O
Support Care Cancer; 2020 Feb; 28(2):561-570. PubMed ID: 31089820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
